The management team of Nibykan Co. has more than 30 years of experience in the Healthcare Business; The main focus of Nibykan is on the pharmaceutical industry and wound management.
Nibykan Co. was established in 2015 in Germany. Our headquarters is located in Frankfurt, The company legal department is in Mannheim, The financial department is in Switzerland (Zurich), and the Fareast regional office is in Sydney, Australia.
Nibykan is the owner of “Cancel Cancer” and “Sanostol” (for Middle East region) brands.
The main target markets of Nibykan Co. are META and CIS countries.
Nibykan has contract manufacturing agreements in different countries.
Strengths of Nibykan
- We Are Creatives
- We Are Professionals
- We work Worldwide
- We Worry about The Quality of our Products and services
To become a leading global healthcare organization with promoting high quality products in order to satisfy our customers.
We are responsible to society. We shall be good corporate citizens and will be driven by high ethical standards in our practices.